MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Xtant Medical Holdings Interest Expense 2011-2025 | XTNT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Xtant Medical Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.16 M | 2.94 M | 1.69 M | 995 K | 5.98 M | 5.77 M | 10.1 M | 14.7 M | 12.3 M | 7.73 M | 5.66 M | 4.65 M | 1.86 M | 1.16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.7 M | 995 K | 5.69 M |
Quarterly Interest Expense Xtant Medical Holdings
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16 K | 1 M | - | -13 K | 992 K | 835 K | - | 760 K | 786 K | 575 K | - | 440 K | 397 K | 359 K | - | 329 K | 199 K | 1 K | - | 2.1 M | 2.05 M | 1.11 M | - | 1.18 M | 1.3 M | 2.02 M | - | 1.79 M | 2.82 M | 3.54 M | - | 3.81 M | 3.33 M | 3.4 M | - | 3.16 M | 2.98 M | 2.83 M | - | 2.11 M | 1.38 M | 1.44 M | - | 1.5 M | 1.44 M | 1.28 M | - | 1.2 M | 1.17 M | 1.06 M | - | 868 K | 266 K | 171 K | - | 541 K | 133 K | 372 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.81 M | -16 K | 1.34 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
24.9 M | $ 21.05 | 0.91 % | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.22 | -0.86 % | $ 662 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.46 | 0.58 % | $ 120 M | USA |
 |
Boston Scientific Corporation
BSX
|
305 M | $ 95.79 | -0.23 % | $ 141 B | USA |
 |
Bio-Rad Laboratories
BIO
|
48.9 M | $ 303.3 | -0.5 % | $ 8.56 B | USA |
 |
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | USA |
 |
Electromed
ELMD
|
78 K | $ 28.78 | -0.17 % | $ 243 M | USA |
 |
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
-38.2 M | $ 47.11 | -0.84 % | $ 7.02 K | USA |
 |
Abbott Laboratories
ABT
|
376 M | $ 125.52 | -0.21 % | $ 218 B | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
232 K | $ 3.25 | 1.25 % | $ 121 M |  France |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
IRadimed Corporation
IRMD
|
164 K | $ 97.18 | -0.6 % | $ 1.23 B | USA |
 |
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | USA |
 |
LivaNova PLC
LIVN
|
1.01 M | $ 61.45 | -1.33 % | $ 3.33 B |  Britain |
|
LENSAR
LNSR
|
660 K | $ 11.62 | -0.09 % | $ 134 M | USA |
 |
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
7.68 M | $ 156.68 | -0.92 % | $ 11.7 B | USA |
 |
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
13 M | $ 0.8 | -0.47 % | $ 82.2 M | USA |
 |
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-40 K | $ 13.44 | -0.96 % | $ 363 M | USA |
 |
FONAR Corporation
FONR
|
347 K | $ 18.55 | -0.27 % | $ 122 M | USA |
 |
AxoGen
AXGN
|
-199 K | $ 32.6 | -0.38 % | $ 1.44 B | USA |
 |
Orthofix Medical
OFIX
|
-9.62 M | $ 15.23 | -0.68 % | $ 581 M |  Curacao |
 |
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | USA |
 |
CONMED Corporation
CNMD
|
37.3 M | $ 40.62 | -1.26 % | $ 1.25 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.93 | -0.19 % | $ 414 M | USA |
 |
Profound Medical Corp.
PROF
|
146 K | $ 7.24 | -1.23 % | $ 180 M | Canada |
 |
Globus Medical
GMED
|
2.2 M | $ 87.76 | -0.17 % | $ 11.9 B | USA |